What is Amnesia & How is it Treated?

Health & Lifestyle
302

Listen to article (english)

Translate to Spanish or other 102 languages!

Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types. Image for illustration purposes
Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types. Image for illustration purposes

Medical News Today

- Advertisement -

Amnesia is when a person can no longer recall information stored in their memory. There are many types of amnesia. Their symptoms can overlap, and a person can have multiple types.

A person who is a little forgetful in their day-to-day life does not have amnesia. Amnesia refers to a large-scale loss of long-term memory due to illness, brain injury, or psychological traum

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/9673?slot_pos=article_3&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-02-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Why It’s Okay for Kids to be Bored
Next article
FDA Proposes Reducing Nicotine Levels in Certain Tobacco Products

More Articles

$281 Million Unlocked to Bridge the Gap in Rural Medical Access

AUSTIN - Governor Greg Abbott announced the Texas Health and Human Services Commission (HHSC) will receive $281 million in federal funding for the second year of Rural Texas Strong, a five-year initiative to improve rural healthcare throughout the state.

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.
- Advertisement -